These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19893330)

  • 1. MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research.
    Schenk S
    Neuropsychobiology; 2009; 60(3-4):130-6. PubMed ID: 19893330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats.
    Daniela E; Brennan K; Gittings D; Hely L; Schenk S
    Pharmacol Biochem Behav; 2004 Apr; 77(4):745-50. PubMed ID: 15099919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration.
    Daniela E; Gittings D; Schenk S
    Behav Neurosci; 2006 Oct; 120(5):1144-50. PubMed ID: 17014264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats.
    van Nieuwenhuijzen PS; Li KM; Hunt GE; McGregor IS
    Neuropsychobiology; 2009; 60(3-4):195-203. PubMed ID: 19893336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.
    Schenk S
    Neurosci Biobehav Rev; 2011 Apr; 35(5):1203-18. PubMed ID: 21184779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ; McGregor IS; Hunt GE; Cornish JL
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between 3,4-methylenedioxymethamphetamine and ethanol in humans and rodents.
    Mohamed WM; Hamida SB; de Vasconcelos AP; Cassel JC; Jones BC
    Neuropsychobiology; 2009; 60(3-4):188-94. PubMed ID: 19893335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats.
    Schenk S; Gittings D; Johnstone M; Daniela E
    Psychopharmacology (Berl); 2003 Aug; 169(1):21-7. PubMed ID: 12774185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.
    Ludwig V; Mihov Y; Schwarting RK
    Behav Brain Res; 2008 May; 189(1):52-64. PubMed ID: 18241937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration.
    Bird J; Schenk S
    Addict Biol; 2013 Jul; 18(4):654-64. PubMed ID: 22784256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain.
    Kindlundh-Högberg AM; Svenningsson P; Schiöth HB
    Neuropharmacology; 2006 Sep; 51(4):838-47. PubMed ID: 16820177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.
    Green AR; O'shea E; Colado MI
    Eur J Pharmacol; 2004 Oct; 500(1-3):3-13. PubMed ID: 15464016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Peterson AL; Gilman TL; Banks ML; Sprague JE
    Synapse; 2006 Apr; 59(5):317-9. PubMed ID: 16421905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration.
    Clemens KJ; Cornish JL; Hunt GE; McGregor IS
    Pharmacol Biochem Behav; 2006 Oct; 85(2):454-63. PubMed ID: 17112571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.